MedTrace Logo

Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery

NCT05188222 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-02-24

No results posted yet for this study

Summary

A randomized, controlled, double-blinded clinical trial evaluating the effect of the administration of a Maltodextrin solution on cardiac function in patients presenting for coronary artery bypass grafting surgery with a reduced left ventricular ejection fraction.

Conditions

  • Left Ventricular Dysfunction
  • Quality of Recovery
  • Right Ventricular Dysfunction

Interventions

DRUG

Maltodextrin solution

The oral preparation of 50 grams of Maltodextrin solution mixed in 400 mL of water

DRUG

Placebo solution

Specifically formulated placebo to provide a similar taste and texture to Maltodextrin, without the same carbohydrate characteristics

Sponsors & Collaborators

  • Jewish General Hospital

    lead OTHER

Principal Investigators

  • Matthew Cameron, MDCM, MPH · McGill University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2026-12-01
Completion
2027-03-01

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05188222 on ClinicalTrials.gov